Seneca Growth Capital Vct Share Discussion Threads

[rivaldo] 01/6/2015 11:32

Looks like someone bought 160,000 shares at 66p this morning. That's almost 2% of the company.

[rivaldo] 01/6/2015 09:14

Worth noting that ODX and EKF are also rising nicely as well as SCLP, especially ODX after today's news.

Today could be a turning point for HYG in terms of NAV. I'll try and update the thread header when I get a chance for the latest shareholdings in SCLP etc.

[rivaldo] 01/6/2015 08:13

SCLP rocketing on the immunotherapy drug news all over the media this morning....

Many thanks for the AGM report timbo. Interesting times!

[timbo003] 17/5/2015 02:15

I have written up a few notes on the AGM on The Motley Fool



That's the most exciting one I've been to so far!

[timbo003] 16/5/2015 08:42

AS you can probably gather from the RNS yesterday, the AGM on Thursday was an exciting affair:



More later.....

[rivaldo] 14/5/2015 12:30

NAV now almost 89p with SCLP, EKF and ODX all rising.

With a large sum invested in OR Productivity it's great to see them starting to break even.

And Hallmarq continues to make very good progress, with lots of good news on its web site:

[timbo003] 02/4/2015 08:55

There was an interesting (but ambiguous) announcement from one of the AIM quoted investee companies this morning (EKF) which may be a prelude to a liquidity event:


This follows shortly after an industry veteran declaring a strategic stake:

[rivaldo] 31/3/2015 08:56

The 2014 results are just out - NAV of 90.4p per share:



Mixed bag really. SCLP and ODX's valuations will have slipped since, but I'm sure Hallmarq must be worth a lot more than the current HYG valuation, which would be crystallised on their IPO.

The Report states "As mentioned later in this statement, several portfolio companies are planning to list on AIM in 2015 and 2016". I can only see reference to Hallmarq in this regard.

Interesting stuff re the broker collaboration for shareholder investment into the portfolio. This is a great idea.

[stupidboypike] 24/3/2015 14:52

rivaldo. I know, I really didn't want to sell but I thought the possibility of HYG going with the trend and falling off a cliff was too strong. Actually it looks now like that might not happen. I may well buy back before too long, although it seems a bit odd buying second hand VCTs without the upfront tax advantage. I have used some of the proceeds to buy some EKF which I also think has a very good long term outlook. Best regards SBP

[rivaldo] 24/3/2015 14:37

Good luck sbp. I really believe you should keep a sharp eye on HYG - Hallmarq is going from strength to strength and should repay an investment here in time imho. And SCLP may today have reversed its trend!

[stupidboypike] 23/3/2015 16:28

Having held these since launch I have just (rather sadly) sold them. Scancell has dropped off a cliff and Oxford VCT has followed, made me too nervous. Shame, I really like the portfolio here. Might even buy back once Scancell becomes clear. GLA

Best regards SBP

[rivaldo] 10/2/2015 10:01

Bit of buying today - and it sounds like Glide Pharma are progressing nicely following successful pre-clinical results:



"Glide Appoints Albany Molecular Research for Manufacture of Novel Octreotide Solid Dose Formulation Clinical Trial Product

26 Jan 2015

OXFORD, UK – 26 January 2015 - Glide Technologies, the development company focused on solid dose formulations of therapeutics and vaccines and non-invasive diagnostics, today announced that it has appointed Albany Molecular Research (Glasgow) Limited (AMRI) to manufacture the company’s novel solid dose injection (SDI) formulation of octreotide, for use in a human bioequivalence study to be conducted in Q4 2015. The appointment follows successful pre-clinical proof-of-concept results, which compared the solid formulation with the currently marketed liquid product (Sandostatin®).

etc"

[rivaldo] 27/10/2014 10:09

Encouraging to see SCLP up to 38.75p. My rough calculation (without a calculator!) has HYG's NAV at around 102p at that level.

[rivaldo] 21/10/2014 14:59

Cooment on Glide from today's Oxford Tech VCT results:



"Glide remains on track for a proof of concept clinical trial in 2015"

And on Scancell:

"Scancell has a vaccine for skin cancer in clinical trials. Early indications on animals are that when Scancell's vaccine is used in combination with checkpoint inhibitors, the success rate for the treatment rises from around 50% to around 85%. If this is borne out by future trials, then Scancell's value may increase significantly. "

[rivaldo] 03/10/2014 10:41

Continuing to move up slowly.

Timbo and myself were at the AGM of Surface Transforms (SCE) recently - their non-exec is Kevin D'Silva, who is also Chairman of Hallmarq. Apart from being extremely pleasant, he confirmed that things at Hallmarq were going very well, confirming my confidence that this could be an extremely good investment for HYG.

OT : SCE are also well worth a look imho. At a mere £7m m/cap the upside after last week's "game-changer" RNS may be huge.

[rivaldo] 14/8/2014 15:14

Nice move up recently. The interims were out 3 days ago and showed a 93p NAV:



As I posted earlier, the Portfolio comments on Hallmarq suggest we may well get some nice surprise at some point soon on its value. IMO this really could be a big winner.

HYG did well to sell some ODX at 31.5p too. I've bought some ODX myself recently as it seems very cheap now to me.

[stupidboypike] 31/7/2014 12:05

More good news from Arecor:-


Best regards SBP

[timbo003] 10/6/2014 09:13

Tristel worth keeping an eye on. Up around 20% today following a trading update and now up around 65% this year, they accounted for 0.6p/share of Hygea's NAV at year end, so that should be more like 1p/share now.

[stupidboypike] 04/6/2014 11:19

More news from Arecor (an investee company) :-



Best regards SBP

[rivaldo] 09/5/2014 14:38

Superb write-up timbo, many thanks. The comments on Hallmarq and OR Productivity are particularly interesting.

It's a shame HYG haven't got more Tristel.

Your comments about inflation re the hurdle price appear to have hit a nerve. Nicely done.

Given the dominance of SCLP within the NAV I'd assume that the discount to NAV will remain large either until SCLP is disposed of/bought out or the likes of Hallmarq etc make visible valuation progress. I'm happy to wait, as the timeframe for either event may not be too far away.

[timbo003] 09/5/2014 12:26

My AGM report is here:



Please feel free to copy or plagiarise as required.

[timbo003] 07/5/2014 16:22

It was the AGM today, I will endeavour to write up a few notes later today (or tomorrow).

Meanwhile a bit of bad news for EKF this morning, down circa 25% as a result, which corresponds to around 1.3p off the NAV for Hygea.

[rivaldo] 07/5/2014 12:23

NAV as at 31/3 is out - it's up to almost 98p:



A fairly quiet quarter, with SCLP holding its own nicely.

[stupidboypike] 02/5/2014 11:09

Nice piece on Arecor (an investee company)



Best regards SBP

[rivaldo] 14/4/2014 12:09

Interesting Hallmarq stuff going on...

Firstly, they're expanding into the next door building as they've "become too big" for the available space:



Secondly, Foresight VCT4 have sold their stake to a VC and other existing investors:



Good news all round methinks. Foresight have made a nice profit, whilst existing investors have topped up:

"Fri Apr 11 10:26:20 BST 2014

Foresight 4 VCT sells stake in Hallmarq Veterinary Imaging Limited to Catamaran Ventures (UK) Limited

Foresight Group is pleased to announce the sale of Foresight 4 VCT "C Shares" entire shareholding in Hallmarq Veterinary Imaging Limited to Catamaran Ventures (UK) Limited and a number of existing shareholders for a consideration of £0.75 million.

The sale represents a return of 1.6x from the point that Foresight took over the mandate to manage this investment in 2011.

During the period of Foresight's involvement at Hallmarq, the business successfully grew its revenue and EBITDA as a result of increasing the number of equine scanners installed worldwide as well as developing and deploying its first PetVet scanner for small animals such as dogs and cats in the UK."